Cargando…

Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application

Hepatocellular carcinoma (HCC) is the subtype of liver cancer with the highest incidence, which is a heterogeneous malignancy with increasing incidence rate and high mortality. For ethical reasons, it is essential to validate medical clinical trials for HCC in animal models before further considerat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Sha, Huang, Fang, Ru, Guoqing, Wang, Yigang, Zhang, Bixiang, Chen, Xiaoping, Chu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279915/
https://www.ncbi.nlm.nih.gov/pubmed/35847898
http://dx.doi.org/10.3389/fonc.2022.902820
_version_ 1784746512465526784
author Liu, Sha
Huang, Fang
Ru, Guoqing
Wang, Yigang
Zhang, Bixiang
Chen, Xiaoping
Chu, Liang
author_facet Liu, Sha
Huang, Fang
Ru, Guoqing
Wang, Yigang
Zhang, Bixiang
Chen, Xiaoping
Chu, Liang
author_sort Liu, Sha
collection PubMed
description Hepatocellular carcinoma (HCC) is the subtype of liver cancer with the highest incidence, which is a heterogeneous malignancy with increasing incidence rate and high mortality. For ethical reasons, it is essential to validate medical clinical trials for HCC in animal models before further consideration on humans. Therefore, appropriate models for the study of the pathogenesis of the disease and related treatment methods are necessary. For tumor research, mouse models are the most commonly used and effective in vivo model, which is closer to the real-life environment, and the repeated experiments performed on it are closer to the real situation. Several mouse models of HCC have been developed with different mouse strains, cell lines, tumor sites, and tumor formation methods. In this review, we mainly introduce some mouse HCC models, including induced model, gene-edited model, HCC transplantation model, and other mouse HCC models, and discuss how to choose the appropriate model according to the purpose of the experiments.
format Online
Article
Text
id pubmed-9279915
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92799152022-07-15 Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application Liu, Sha Huang, Fang Ru, Guoqing Wang, Yigang Zhang, Bixiang Chen, Xiaoping Chu, Liang Front Oncol Oncology Hepatocellular carcinoma (HCC) is the subtype of liver cancer with the highest incidence, which is a heterogeneous malignancy with increasing incidence rate and high mortality. For ethical reasons, it is essential to validate medical clinical trials for HCC in animal models before further consideration on humans. Therefore, appropriate models for the study of the pathogenesis of the disease and related treatment methods are necessary. For tumor research, mouse models are the most commonly used and effective in vivo model, which is closer to the real-life environment, and the repeated experiments performed on it are closer to the real situation. Several mouse models of HCC have been developed with different mouse strains, cell lines, tumor sites, and tumor formation methods. In this review, we mainly introduce some mouse HCC models, including induced model, gene-edited model, HCC transplantation model, and other mouse HCC models, and discuss how to choose the appropriate model according to the purpose of the experiments. Frontiers Media S.A. 2022-06-30 /pmc/articles/PMC9279915/ /pubmed/35847898 http://dx.doi.org/10.3389/fonc.2022.902820 Text en Copyright © 2022 Liu, Huang, Ru, Wang, Zhang, Chen and Chu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Sha
Huang, Fang
Ru, Guoqing
Wang, Yigang
Zhang, Bixiang
Chen, Xiaoping
Chu, Liang
Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application
title Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application
title_full Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application
title_fullStr Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application
title_full_unstemmed Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application
title_short Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application
title_sort mouse models of hepatocellular carcinoma: classification, advancement, and application
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279915/
https://www.ncbi.nlm.nih.gov/pubmed/35847898
http://dx.doi.org/10.3389/fonc.2022.902820
work_keys_str_mv AT liusha mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication
AT huangfang mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication
AT ruguoqing mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication
AT wangyigang mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication
AT zhangbixiang mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication
AT chenxiaoping mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication
AT chuliang mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication